Related Experiment Videos
Mutation analysis of copper-transporting P-type adenosine triphosphatase (ATP7B) in human solid carcinomas
Atsuko Kanzaki1, Kentaro Nakayama, Hitoshi Miyashita
1Department of Pathology, Institute of Development, Aging and Cancer, Tohoky University, Sendai, Japan.
Anticancer Research
|June 25, 2003
Summary
Analyzing the ATP7B gene and protein may help guide chemotherapy choices for solid carcinomas. Mutations in key ATP7B domains were not found in breast, gastric, or oral cancers, suggesting other factors influence cisplatin resistance.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cisplatin resistance is a significant challenge in treating human solid carcinomas.
- The copper-transporting P-type adenosine triphosphatase (ATP7B) is implicated in cisplatin resistance and overexpressed in various carcinomas.
- ATP7B's role in metal transport is linked to its copper-binding and ATP-binding domains.
Purpose of the Study:
- To investigate mutations within the copper-binding and ATP-binding domains of ATP7B.
- To determine if ATP7B gene mutations contribute to cisplatin resistance in specific solid carcinomas.
- To explore the potential of ATP7B analysis for optimizing chemotherapy selection.
Main Methods:
- Mutation analysis of the six copper-binding domain and ATP-binding domain of the ATP7B gene.
- Focus on human solid carcinoma samples, including breast, gastric, and oral squamous cell carcinomas.
Main Results:
- No mutations were detected in the analyzed copper-binding and ATP-binding domains of ATP7B.
- This finding was consistent across breast, gastric, and oral squamous cell carcinoma samples.
- The study did not find direct evidence of mutations in these specific ATP7B domains causing cisplatin resistance.
Conclusions:
- The absence of mutations in the key functional domains of ATP7B suggests that other mechanisms contribute to cisplatin resistance.
- ATP7B gene and/or protein analysis may still be valuable for predicting chemotherapy response.
- Further research is needed to fully elucidate the complex relationship between ATP7B and chemoresistance in solid tumors.